EP3240801
SAMSETT ÓNÆMISMEÐFERÐ VIÐ ÆXLI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.12.2015EP published:
20.1.2021EP application number:
15876030.6
EP translation filed:
1.2.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
21.12.2035Expiry date:
21.12.2026Next due date:
31.12.2026
Title:
COMBINATION TUMOR IMMUNOTHERAPY
Timeline
Today
22.12.2015EP application
20.1.2021EP Publication
1.2.2021Translation submitted
15.2.2021Registration published
21.12.2026Expires
Owner
Name:
Checkmate Pharmaceuticals, Inc.Address:
1 Broadway, 14th Floor, Cambridge, MA 02142, US
Inventor
Name:
KRIEG, Arthur, M.Address:
Cambridge, MA 02138, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462098568 PDate:
31.12.2014Country:
US
Number:
201562106526 PDate:
22.1.2015Country:
US
Number:
201562118165 PDate:
19.2.2015Country:
US
Classification
Categories:
A61K 31/7125, C07K 14/56, A61P 35/00, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.11.2021
Expires: 21.12.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 22.11.2022
Expires: 21.12.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.12.2023
Expires: 21.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.11.2024
Expires: 21.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 15.12.2025
Expires: 21.12.2026
Payer: Árnason Faktor ehf.